Christopher Birch, Ph.D.Research Associate, Landers Laboratory
Mallikarjunarao Ganesana, Ph.D.Research Associate, Venton Laboratory
Ana GeerResearch Associate
Ana Geer conducted her PhD studies at the University of Zaragoza, Spain under the supervision of M. A. Ciriano and C. Tejel on the synthesis and coordination chemistry of group 9 transition metals (Rh and Ir) combined with anionic ligands, such as tris (phosphino)borate and tris(pyrazolyl)borate ligands. During this time, she undertook a three-month stay at the properties) is investigated. Laboratoire de Chimie de Coordination (LCC) in Toulouse under the guidance of S. Sabo-Etienne and S. Bontemps to work on CO2 hydroboration. In 2015 she joined the groups of Champness and Kays in the University of Nottingham as a research fellow where her work focused on the synthesis and reactivity studies of low-coordinate transition metal complexes. Currently, Ana is working as a Research Associate with Professor Brent Gunnoe on the design and preparation of new materials for alkane oxidation.
Tao HuangResearch Associate
Tao received his B.S. from Wuhan University in China and earned his Ph.D. in medicinal chemistry from the University of Virginia, under the supervision of Professor Timothy Macdonald. His Ph.D. work focused on chemical biology study of Sphingosine 1-Phosphate (S1P) receptors and Sphingosine Kinases for immune modulation, which is directly relevant to human diseases such as autoimmune disorder and cancer. During his post-doc training in UVA’s School of Medicine, he extended his expertise into molecular imaging and nanotechnology for cancer diagnosis and therapy. In the Hsu lab, Tao will be working on immunotherapy for cancers.
Jennifer Martin, Ph.D.Research Associate, Columbus Laboratory
Boobalan PachaiyappanResearch Associate, Hsu Lab
Boobalan received his Master’s Degree in Chemistry from Virginia Tech, and his Ph.D. in Medicinal Chemistry from the University of Illinois at Chicago. He is a trained medicinal chemist whose research interests lie on the interface of computer-assisted drug design methods and organic synthesis. During his research years, he worked in several therapeutic areas, including Alzheimer's, oncology, infection (antibacterial and antimalarial) and epilepsy. Boobalan published his findings in 13 peer-reviewed journals. Owing to his contributions to the field of medicinal chemistry, the American Chemical Society bestowed upon him the highly prestigious Robert M. Scarborough Post-Graduate Excellence award in Medicinal Chemistry.
In the Hsu lab, Boobalan will be engaged in activities involving synthesis of all activity-based probes and small molecular inhibitors.